
SNYR Stock Forecast & Price Target
SNYR Analyst Ratings
Bulls say
Synergy CHC is a well-established provider of consumer health care, beauty, and lifestyle products with a strong brand portfolio and growth opportunities in the brain health supplements, energy RTD, and international markets. Despite competition, the company has a solid financial track record and a healthy balance sheet. Initiating coverage with a BUY rating and a $5 price target, the stock may continue its recent growth trajectory but will need to closely monitor consumer trends to maintain this positive outlook.
Bears say
Synergy CHC is relatively new to the market, and although it has some successful and popular products, it has faced challenges with its recent ME distribution deal being canceled, causing a significant decrease in revenue. Additionally, the company's profitability and growth have been driven by its flagship brand FOCUSfactor, which may not be sustainable in the long term as it competes in a crowded market. The company's financials have been solid, but there are risks involved in the highly competitive health and wellness industry, and small/micro cap stocks may be susceptible to market volatility and fluctuations.
This aggregate rating is based on analysts' research of Synergy CHC Corp and is not a guaranteed prediction by Public.com or investment advice.
SNYR Analyst Forecast & Price Prediction
Start investing in SNYR
Order type
Buy in
Order amount
Est. shares
0 shares